SomnoDent Fusion is an FDA 510(k)-cleared, class II medical device manufactured under 21 CFR 820 and ISO13485 standards. Significant clinical benefits have been demonstrated in 15 independent studies, one with 91% of patients reporting improvement in sleep quality with SomnoDent.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width="1/2"][vc_single_image image="6710" img_size="medium" alignment="center" style="vc_box_rounded"][/vc_column][vc_column width="1/2"][vc_column_text]
The calibration flexibility offered in the SomnoDent Fusion means that it does not have to be reset as frequently, and less resets means your patients won’t be without their device during manufacturer adjustments. With device wings that are closer to the occlusal surface, patients experience more room in their mouths and less bulk! Along with the flexibility in adjustment, the SomnoDent Fusion provides an 8.5mm advancement – longer than most other dorsal fin oral devices. The SomnoDent Fusion can also be made with SMH BFlex material, which creates greater comfort for your patients. Ultimately, the SomnoDent Fusion saves your office time and money with our drop-in fit, along with less device adjustments afterwards.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] here to view the full evaluation and report. [/vc_column_text][vc_separator][vc_column_text][another_content] "I LOVE the new Fusion oral appliance by SomnoMed. With the wing movement of 1 mm each, and the capability of changing out 4 different wings,plus the original maxillary screw mechanism that allows 6mm of movement ... this gives the dentist a lot of options/combinations of movement to get the patient to an optimal and therapeutic spot to manage their sleep apnea. This will be my go to appliance for a long time." - Dr. Erika Mason, DDS, Diplomate-ABDSM, Diplomate-ACSDD [/another_content] [gallery columns="4" ids="1705,1704,1691,1677"]
Tavoitteenamme on toimittaa asiakkaillemme ja potilaillemme huippulaadukkaita tuotteita obstruktiivisen uniapnean (OSAS) hoitoa varten.
Käytännön työmme pohjautuu henkilökohtaisiin arvoihimme: koskemattomuus, asiakassuuntaisuus, ihmiset/potilaat, tiimissä työskentely, laatu, kunnioitus ja innovaatio.
SomnoMed is a publicly traded company on the Australian Stock Exchange (ASX:SOM). Please visit our Investor section.
© 2021 SomnoMed.com.